RET Codon 634 Mutations in Multiple Endocrine Neoplasia Type 2: Variable Clinical Features and Clinical Outcome
Authors:
- 1 June 2003
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (6) , 2644-2649
Abstract
Since the establishment of a protocol for molecular analysis of hereditary medullary thyroid carcinoma (MTC) in southern Brazil, in 1997, 17 independent families with RET germline mutation have been identified. Because neither molecular diagnosis nor the pentagastrin test were available before the establishment of this protocol, we had the opportunity to observe a large number of patients in whom the disease has evolved naturally without medical intervention, namely prophylactic thyroidectomy. We observed a wide spectrum in terms of clinical presentation and natural course of the disease even among genetically related individuals. Sixty-nine individuals from 12 different families presented a codon 634 mutation, the most prevailing missense mutation in our series. The specific mutations identified were C634Y (n = 49), C634R (n = 13), and C634W (n = 7). Individuals with the C634R mutation presented significantly more distant metastases at diagnosis than subjects with the C634Y or C634W mutations (54.5% vs. 19.4% vs. 14.3%, respectively, P = 0.03). Further analysis of the estimated cumulative frequency of lymph node and/or distant metastases by Kaplan-Meier curves showed that the appearance of lymph nodes and metastases occurred later in patients with C634Y than in those with C634R (P = 0.001). Our results suggest that specific nucleotide and amino acid exchanges at codon 634 might have a direct impact on tumor aggressiveness in MEN 2A syndrome.Keywords
This publication has 20 references indexed in Scilit:
- The TNM system: Our language for cancer careJournal of Surgical Oncology, 2002
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2The Journal of Clinical Endocrinology & Metabolism, 2001
- Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of PatientsThe Journal of Clinical Endocrinology & Metabolism, 2001
- Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?Cancer, 2000
- Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteinesOncogene, 1998
- The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2JAMA, 1996
- APPLICATION OF GENETIC SCREENING INFORMATION TO THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Endocrinology and Metabolism Clinics of North America, 1996
- Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation ConsortiumJournal of Internal Medicine, 1995
- Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2BScience, 1995
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993